logo-loader
viewMarrone Bio Innovations

Marrone Bio closes its acquisition of Finland-based Pro Farm Technologies OY

With the Pro Farm acquisition, the California-based company is adding to its portfolio proprietary nutrient and biostimulant technology as well as products for seed and foliar treatments

Marrone Bio Innovations -
Marrone Bio provides bio-based pest management and plant health products for the US and international agricultural and water markets

Marrone Bio Innovations Inc (NASDAQ:MBII) announced Monday its acquisition of Finland-based Pro Farm Technologies OY has closed.

In a statement, the California-based company said that with the Pro Farm acquisition it is adding to its portfolio proprietary nutrient and biostimulant technology as well as products for seed and foliar treatments.

The deal has an agreed enterprise value of $31.8 million, Marrone Bio said.  

That includes a combination of $6.2 million cash and 12.7 million shares of Marrone Bio stock paid to Pro Farm’s equity holders, debt holders and advisors as well as the opportunity for potential payment of a total of up to $7.5 million of additional shares deliverable from 2021 through 2024 based agreed commercial milestones being achieved.

READ: Marrone Bio grows business with acquisition of rights, assets to Jet Ag, Jet Oxide product lines

As a result of the acquisition, Pro Farm has become a wholly-owned subsidiary of Marrone Bio.

“I am pleased to announce the completion of our strategic acquisition of Pro Farm, which not only provides Marrone Bio with an exciting, complementary technology but with an expanded global distribution network for our entire product portfolio as well,” said Marrone CEO Pam Marrone.

“The addition of Pro Farm to our platform is expected to be accretive to net income and cash flow from operations in 2020. We look forward to further leveraging our technology and products across all three fast-growing biologicals categories of bioprotection, biostimulants and bionutrition.”

Furthermore, Pro Farm and Corteva Agriscience of Wilmington, Delaware have recently announced a strategic, long-term exclusive commercial agreement in Europe as part of Pro Farm’s expansion plans, the company said.

Together, both companies will develop and commercialize a suite of seed-applied biological products based on Pro Farm’s proprietary technology platform.

Corteva Agriscience will launch the first corn, sunflower and oilseed rape products based on Pro Farm’s biological platform in Europe in the 2020-2021 season, with a target treatment coverage of more than 10 million hectares, or about 25 million acres.

Marrone Bio provides bio-based pest management and plant health products for the US and international agricultural and water markets.

Contact the author: [email protected]

Follow him on Twitter @PatrickMGraham

Quick facts: Marrone Bio Innovations

Price: 1.38 USD

NASDAQ:MBII
Market: NASDAQ
Market Cap: $170.33 m
Follow

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Marrone Bio Innovations named herein, including the promotion by the Company of Marrone Bio Innovations in any Content on the Site, the Company...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Full interview: Marrone Bio Innovations' Stargus biofungicide gets the green...

Marrone Bio Innovations Inc (NASDAQ:MBII) CEO Pam Marrone Skyped in from the Regenerative Food Systems Investments Forum in Oakland, to tell Proactive that the California-based company's Bacillus biofungicide, marketed in the US as Stargus for specialty crops, has been approved for use in...

2 weeks ago

2 min read